Filter
3850
Filtered Results: 3850
Text search:
impact
of
emergencies
Featured
Recommendations
407
New Publications
965
Language
Document type
No document type
1863
Studies & Reports
777
Guidelines
524
Manuals
258
Strategic & Response Plan
228
Fact sheets
67
Training Material
54
Situation Updates
49
Resource Platforms
9
Infographics
8
Online Courses
8
Brochures
5
Countries / Regions
Global
187
India
127
Kenya
102
Ethiopia
81
Sierra Leone
79
Myanmar / Burma
79
Syria
78
Liberia
74
Latin America and the Carribbean
68
Nigeria
65
Nepal
65
Western and Central Europe
65
Africa
59
Uganda
55
South Africa
55
Bangladesh
48
South Sudan
46
Ukraine
40
Congo, Democratic Republic of
36
Tanzania
35
Rwanda
35
Ghana
34
South–East Asia Region
32
Malawi
31
Yemen
29
Zambia
28
Senegal
26
Guinea
25
Indonesia
25
Mozambique
25
Namibia
25
Philippines
24
Middle East and North Africa
22
Haiti
21
Sudan
21
Venezuela
21
Afghanistan
20
Brazil
20
West and Central Africa
20
Pakistan
19
East and Southern Africa
19
Zimbabwe
18
Eastern Europe
18
Somalia
17
Cambodia
17
Asia
17
Jordan
16
Lebanon
16
Russia
16
Eastern Europe and Central Asia
15
Lesotho
14
Colombia
13
Western Pacific Region
12
Burkina Faso
11
Iraq
11
Germany
11
Vietnam
11
Mali
10
Cameroon
9
Peru
9
Laos
9
USA
8
Thailand
8
Central African Republic
8
Eswatini/ Swaziland
8
Botswana
8
Chile
8
Niger
7
Turkey
7
Ecuador
7
Libya
7
Moldova
7
Saudi Arabia
6
Egypt
6
China
6
Argentina
6
Madagascar
6
Iran
6
Spain
6
Côte d’Ivoire / Ivory Coast
5
Chad
5
Papua New Guinea
5
Burundi
5
Bolivia
5
Sri Lanka
5
Benin
4
El Salvador
4
Angola
4
Paraguay
4
Fiji
4
Georgia
4
Turkmenistan
4
Tunisia
4
Morocco
3
Togo
3
Malaysia
3
Honduras
3
Bhutan
3
Palestine
3
Italy
3
Southern Africa
3
Timor Leste/ East Timor
3
Kazakhstan
3
North America
3
Mauritius
3
Belarus
3
Gambia
2
Mauritania
2
North Macedonia
2
Serbia
2
Croatia
2
Greece
2
Guatemala
2
Mexico
2
North Korea
2
Albania
2
Djibouti
2
Tajikistan
2
Qatar
2
Gabon
2
Japan
2
France
2
United Kingdom
2
Portugal
2
Guinea-Bissau
1
Vanuatu
1
Dominican Republic
1
Hungary
1
Cuba
1
Nicaragua
1
Other region
1
Solomon Islands
1
Poland
1
Armenia
1
Congo-Brazzaville
1
Canada
1
Bulgaria
1
Romania
1
Uzbekistan
1
Kyrgyzstan
1
Denmark
1
Belgium
1
Maldives
1
South Korea
1
Azerbaijan
1
Israel
1
Bosnia and Herzegovina
1
Authors & Publishers
Publication Years
Category
Countries
1243
Key Resources
276
Clinical Guidelines
251
Public Health
225
Women & Child Health
199
Capacity Building
83
Pharmacy & Technologies
23
Annual Report MEDBOX
1
General Guidelines
1
Protection & Security
1
Toolboxes
COVID-19
504
Mental Health
268
AMR
211
Planetary Health
200
Conflict
194
Rapid Response
182
HIV
151
TB
141
Disability
118
Ebola
115
Natural Hazards
115
Refugee
99
Caregiver
90
Global Health Education
80
NTDs
58
Pharmacy
46
Specific Hazards
41
Health Financing Toolbox
41
NCDs
37
Polio
35
Zika
34
Cholera
31
Social Ethics
5
Typhoon
4
South Sudan
2
Health Financing
1
Education on the move
The International Pharmaceutical Federation (FIP) is a global federation of national associations of pharmacists and
pharmaceutical scientists. In order to support these associations in their fight...
The purpose of this guidance is to assist WHO Member States, and other stakeholders, in the establishment and development of programmes of integrat...
The current document is anupdate of the guidelines developed by the EUCAST subcommittee on detection of resistance mechanisms. The EUCAST Steering Committee has carried out the current update. The d...
The World Health Organization organized a Consultation of National Leprosy Programme managers, partners and affected persons to discuss the draft Global Leprosy Strategy, 2021--2030. This virtual event took place from 26 to 30 October 2020. It was a...
Policy Brief.
Our understanding of how to diagnose and manage Long COVID is still evolving but the condition can be very debilitating. It is associated with a range of overlapping symptoms includin...
This document aims to describe a minimum set of surveillance activities recommended at the national level to detect and monitor the relative prevalence of SARS-CoV-2 variants and outline a set ... activities for the characterization and assessment of risk posed by these variants. A set of indicators is also provided to standardize monitoring and public reporting of variant circulation.
The document is primarily intended for national and sub-national public health authorities and partners who support implementation of surveillance for SARS-CoV-2 variants
Climate change and variability is affecting maize (Zea mays L.) production in eastern Ethiopia but how farmers perceive the challenge and respond to it is not well documented. A study was conducted to analyze smallholder maize farmers’ perception of...
Religion and Development 01/2019. Discussion Paper Series of the Research Programme on Religious Communities and Sustainable Development
While COVID-19 virus continues to circulate and evolve, new variants are constantly emerging. Most of the current COVID-19 cases are driven by the circulation of the BA.5 subvariant ... Omicron. The COVID-19 vaccines are being updated with Omicron variants to provide broader immunity against circulating and emerging variants.
Front Chem. 2021; 9: 622286.
Published online 2021 Mar 12. doi: 10.3389/fchem.2021.622286
Revised and expanded version of the Guidelines
Schistosomiasis is widely recognized as a disease that is socially determined. An understanding of the social and behavioural factors linked to disease transmission and control should play a vital role in designing policies and strategies for schist...
Schistosomiasis is widely recognized as a disease that is socially determined. An
understanding of the social and behavioural factors linked to disease transmission and
control should play a vital role in designing policies and strategies for schi...
Heart failure with a reduced ejection fraction (HFrEF) is a condition frequently encountered by healthcare professionals and, in order to achieve the best outcomes for patients, needs to be managed optimally. This guideline document is based on the European Society ... Cardiology Guidelines for the treatment of acute and chronic heart failure published in 2016, and summarises what is considered the best current management of patients with the condition. It provides information on the definition, diagnosis and epidemiology of HFrEF in the African context. The best evidence-based treatments for HFrEF are discussed, including established therapies (beta-blockers, ACE-i/ARBs, mineralocorticoid receptor antagonists (MRAs), diuretics) that form the cornerstone of heart failure management as well as therapies that have only recently entered clinical use (angiotensin receptor-neprilysin inhibitor (ARNI), sodium/glucose cotransporter-2 (SGLT2) inhibitors). Guidance is offered in terms of more invasive therapies (revascularisation, implantable cardioverter defibrillators (ICDs) and cardiac resynchronisation therapy (CRT) by implantation of a biventricular pacemaker with (CRT-D) or without (CRT-P) an ICD, left ventricular assist device (LVAD) use and heart transplantation) in order to ensure efficient use of these expensive treatment modalities in a resourcelimited environment. Furthermore, additional therapies (digoxin, hydralazine and nitrates, ivabradine, iron supplementation) are discussed and advice is provided on general preventive strategies (vaccinations). Sections to discuss conditions that are particularly prevalent in sub-Saharan Africa (HIV-associated cardiomyopathy (CMO), peripartum CMO, rheumatic heart disease, atrial fibrillation) have been added to further improve clinical care for these commonly encountered disease processes.
This review examines high-quality research evidence that synthesises the efects of extreme heat on human health in tropical
Africa. Web of Science (WoS) was used to identify research articles on th...
The pharmacological management of asthma has changed considerably in recent decades, as it has come to be understood that it is a complex, heterogeneous disease with different phenotypes and endotypes. It is now clear that the goal ... asthma treatment should be to achieve and maintain control of the disease, as well as to minimize the risks (of exacerbations, disease instability, accelerated loss of lung function, and adverse treatment effects). That requires an approach that is personalized in terms of the pharmacological treatment, patient education, written action plan, training in correct inhaler use, and review of the inhaler technique at each office visit. A panel of 22 pulmonologists was invited to perform a critical review of recent evidence of pharmacological treatment of asthma and to prepare this set of recommendations, a treatment guide tailored to use in Brazil. The topics or questions related to the most significant changes in concepts, and consequently in the management of asthma in clinical practice, were chosen by a panel of experts. To formulate these recommendations, we asked each expert to perform a critical review of a topic or to respond to a question, on the basis of evidence in the literature. In a second phase, three experts discussed and structured all texts submitted by the others. That was followed by a third phase, in which all of the experts reviewed and discussed each recommendation. These recommendations, which are intended for physicians involved in the treatment of asthma, apply to asthma patients of all ages.
